Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir-Reference-Cited by-同舟云学术

Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir

Published:2020-08-14 Issue:12 Volume:33 Page:1588-1594
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Abdo Mahmoud,Rabiee Ahmed,Abdellatif Zeinab,Abdel Alem Shereen,Moustafa Ahmed

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.;Moucari;Gastroenterology,2008

2. Abnormalities of lipid metabolism in hepatitis C virus infection.;Negro;Gut,2010

3. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.;Antonelli;World J Diabetes,2014

4. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.;Naing;World J Gastroenterol,2012

5. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.;Elkrief;Hepatology,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis;Journal of Viral Hepatitis;2024-07-24

2. Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis;Lipids in Health and Disease;2024-03-09

3. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review;Liver International;2024-02-22

4. Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals;Journal of Clinical Medicine;2022-09-29

5. The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C;Minerva Gastroenterology;2021-10